Etanercept as a salvage treatment for refractory aplastic anemia.

Etanercept as a salvage treatment for refractory aplastic anemia.

Item
http://www.wikidata.org/entity/Q44592963
Tumor necrosis factor-α inhibitors and chronic hepatitis C: a comprehensive literature reviewEtanercept-associated transient bone marrow aplasia: a review of the literature and pathogenetic mechanisms.Altered expression of the TCR signaling related genes CD3 and FcεRIγ in patients with aplastic anemiaMyelodysplasia and acute leukemia as late complications of marrow failure: future prospects for leukemia prevention.Treatment of refractory or relapsed acquired aplastic anemia: review of established and experimental approaches.Aplastic anemia: immunosuppressive therapy in 2010.Tumor necrosis factor restricts hematopoietic stem cell activity in mice: involvement of two distinct receptorsBone marrow angiogenesis in patients presenting with differential Chinese medicine syndrome: correlation with the clinico-pathological features of aplastic anemia.Eosinophilia during Psoriasis Treatment with TNF Antagonists
P2860

Etanercept as a salvage treatment for refractory aplastic anemia.

Item
http://www.wikidata.org/entity/Q44592963
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Etanercept as a salvage treatment for refractory aplastic anemia.
@en
Etanercept as a salvage treatment for refractory aplastic anemia.
@nl
type
label
Etanercept as a salvage treatment for refractory aplastic anemia.
@en
Etanercept as a salvage treatment for refractory aplastic anemia.
@nl
prefLabel
Etanercept as a salvage treatment for refractory aplastic anemia.
@en
Etanercept as a salvage treatment for refractory aplastic anemia.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Etanercept as a salvage treatment for refractory aplastic anemia
@en
P2093
P304
P31
P356
P433
P478
P50
P577
P698